Company at a Glance
VIDEO
📊 Get full analytics about Astellas Pharma
Sign up for free
or
log in
📥 Get our free eBook now: "The Checklist Value Investor — A Smarter Way to Pick Stocks"
Price
Overview
Astellas Pharma is a Japanese pharmaceutical company that was created in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company focuses on the research, development, and commercialization of pharmaceutical products in a variety of therapeutic areas, including immunology, oncology, and urology.
What is special about the company?
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
📚 Your free copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks" is waiting
VGhlcmUgYX JlIGEgZmV3 IHRoaW5ncy B0aGF0IGFy ZSBzcGVjaW FsIGFib3V0 IEFzdGVsbG FzIFBoYXJt YSBhcyBhIG NvbXBhbnk6 PGJyPjEuIF N0cmVuZ3Ro IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudDog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIH N0cm9uZyBm b2N1cyBvbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIHdpdG ggYSBzaWdu aWZpY2FudC Bwb3J0aW9u IG9mIGl0cy ByZXZlbnVl cyBiZWluZy BpbnZlc3Rl ZCBpbiB0aG lzIGFyZWEu IFRoaXMgaG FzIGFsbG93 ZWQgdGhlbS B0byBkZXZl bG9wIGlubm 92YXRpdmUg bWVkaWNpbm VzIGFuZCB0 cmVhdG1lbn RzIGZvciBh IHdpZGUgcm FuZ2Ugb2Yg aWxsbmVzc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgcHJlc2Vu Y2U6IEFzdG VsbGFzIFBo YXJtYSBpcy BhIHRydWx5 IGdsb2JhbC Bjb21wYW55 LCB3aXRoIG xvY2F0aW9u cyBhbmQgb3 BlcmF0aW9u cyBpbiBvdm VyIDUwIGNv dW50cmllcy B3b3JsZHdp ZGUuIFRoaX MgaGFzIGVu YWJsZWQgdG hlbSB0byBy ZWFjaCBhIG Jyb2FkIG1h cmtldCBhbm QgcHJvdmlk ZSB0aGVpci Bwcm9kdWN0 cyBhbmQgc2 VydmljZXMg dG8gYSBkaX ZlcnNlIHJh bmdlIG9mIH BhdGllbnQg cG9wdWxhdG lvbnMuPGJy PjMuIFBhdG llbnQtY2Vu dHJpYyBhcH Byb2FjaDog QXN0ZWxsYX MgUGhhcm1h IHByaW9yaX RpemVzIHRo ZSBuZWVkcy BhbmQgd2Vs bC1iZWluZy BvZiBwYXRp ZW50cyBhYm 92ZSBhbGwg ZWxzZS4gVG hleSBzdHJp dmUgdG8gdW 5kZXJzdGFu ZCB0aGUgbm VlZHMgb2Yg cGF0aWVudH MgYW5kIHdv cmsgdG8gZG V2ZWxvcCB0 cmVhdG1lbn RzIHRoYXQg YWRkcmVzcy B0aGVpciBz cGVjaWZpYy Bjb25kaXRp b25zLjxicj 40LiBDb21t aXRtZW50IH RvIHN1c3Rh aW5hYmlsaX R5OiBUaGUg Y29tcGFueS BoYXMgYSBz dHJvbmcgY2 9tbWl0bWVu dCB0byBzdX N0YWluYWJp bGl0eSwgaW 1wbGVtZW50 aW5nIGVjby 1mcmllbmRs eSBwcmFjdG ljZXMgYW5k IGluaXRpYX RpdmVzIGlu IGl0cyBvcG VyYXRpb25z IGFuZCBwcm 9kdWN0aW9u IHByb2Nlc3 Nlcy4gVGhl eSBhbHNvIH dvcmsgdG8g ZW5zdXJlIG V0aGljYWwg YW5kIHJlc3 BvbnNpYmxl IGJ1c2luZX NzIHByYWN0 aWNlcy48Yn I+NS4gQ29s bGFib3JhdG l2ZSBwYXJ0 bmVyc2hpcH M6IEFzdGVs bGFzIFBoYX JtYSBiZWxp ZXZlcyBpbi Bjb2xsYWJv cmF0aW9uIG FuZCB3b3Jr aW5nIHdpdG ggb3RoZXIg Y29tcGFuaW VzLCBvcmdh bml6YXRpb2 5zLCBhbmQg aW5kaXZpZH VhbHMgdG8g YWNoaWV2ZS B0aGVpciBt aXNzaW9uIG 9mIGltcHJv dmluZyB0aG UgbGl2ZXMg b2YgcGF0aW VudHMuIFRo ZXkgaGF2ZS Bmb3JtZWQg cGFydG5lcn NoaXBzIHdp dGggdmFyaW 91cyBhY2Fk ZW1pYyBpbn N0aXR1dGlv bnMsIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMsIGFu ZCBvdGhlci BwaGFybWEg Y29tcGFuaW VzIHRvIGFk dmFuY2UgaG VhbHRoY2Fy ZSBpbm5vdm F0aW9uLjxi cj42LiBDb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Oi BBc3RlbGxh cyBQaGFybW EgaXMgY29t bWl0dGVkIH RvIGdpdmlu ZyBiYWNrIH RvIHRoZSBj b21tdW5pdH kgYW5kIGlt cHJvdmluZy BwZW9wbGUn cyBsaXZlcy B0aHJvdWdo IGl0cyBjb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5IG luaXRpYXRp dmVzLiBUaG lzIGluY2x1 ZGVzIGludm VzdGluZyBp biBlZHVjYX Rpb24sIHBy b21vdGluZy BlbXBsb3ll ZSBkaXZlcn NpdHkgYW5k IGluY2x1c2 lvbiwgYW5k IHN1cHBvcn RpbmcgbG9j YWwgY29tbX VuaXRpZXMu
What the company's business model?
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
📖 Get insights from "The Checklist Value Investor — A Smarter Way to Pick Stocks" now!
QXN0ZWxsYX MgUGhhcm1h IGlzIGEgZ2 xvYmFsIHBo YXJtYWNldX RpY2FsIGNv bXBhbnkgdG hhdCBmb2N1 c2VzIG9uIG RldmVsb3Bp bmcsIG1hbn VmYWN0dXJp bmcsIGFuZC BtYXJrZXRp bmcgaW5ub3 ZhdGl2ZSBh bmQgaGlnaC 1xdWFsaXR5 IG1lZGljaW 5lcyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiB2YXJpb3 VzIGRpc2Vh c2VzIGFuZC Bjb25kaXRp b25zLiBJdH MgYnVzaW5l c3MgbW9kZW wgcmV2b2x2 ZXMgYXJvdW 5kIHRoZSBm b2xsb3dpbm cga2V5IGFz cGVjdHM6PG JyPjEuIFJl c2VhcmNoIG FuZCBEZXZl bG9wbWVudC AoUiZEKTog QXN0ZWxsYX MgUGhhcm1h IGludmVzdH MgaGVhdmls eSBpbiBSJk QgdG8gZGlz Y292ZXIgYW 5kIGRldmVs b3AgbmV3IG RydWdzIGFu ZCB0cmVhdG 1lbnRzLiBU aGUgY29tcG FueSBoYXMg YSBnbG9iYW wgbmV0d29y ayBvZiByZX NlYXJjaCBj ZW50ZXJzIG FuZCBlbXBs b3lzIGEgdG VhbSBvZiBz Y2llbnRpc3 RzIGFuZCBy ZXNlYXJjaG VycyB3aG8g d29yayBjb2 xsYWJvcmF0 aXZlbHkgdG 8gaWRlbnRp ZnkgYW5kIG RldmVsb3Ag cG90ZW50aW FsIGRydWcg Y2FuZGlkYX Rlcy48YnI+ Mi4gU3RyYX RlZ2ljIFBh cnRuZXJzaG lwcyBhbmQg Q29sbGFib3 JhdGlvbnM6 IEFzdGVsbG FzIFBoYXJt YSBjb2xsYW JvcmF0ZXMg d2l0aCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG FjYWRlbWlj IGluc3RpdH V0aW9ucywg YW5kIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMgdG8g YWNjZXNzIG 5ldyB0ZWNo bm9sb2dpZX MsIHNoYXJl IGtub3dsZW RnZSwgYW5k IGFkdmFuY2 UgaXRzIFIm RCBlZmZvcn RzLiBUaGUg Y29tcGFueS BhbHNvIHNl ZWtzIHRvIG FjcXVpcmUg b3IgbGljZW 5zZSBwcm9t aXNpbmcgY2 9tcG91bmRz IGFuZCB0ZW Nobm9sb2dp ZXMgZnJvbS BleHRlcm5h bCBzb3VyY2 VzIHRvIGV4 cGFuZCBpdH MgcHJvZHVj dCBwaXBlbG luZS48YnI+ My4gTWFudW ZhY3R1cmlu ZyBhbmQgU3 VwcGx5IENo YWluOiBBc3 RlbGxhcyBQ aGFybWEgaG FzIGEgZ2xv YmFsIG1hbn VmYWN0dXJp bmcgYW5kIH N1cHBseSBu ZXR3b3JrIH RoYXQgcHJv ZHVjZXMgYW 5kIGRpc3Ry aWJ1dGVzIG l0cyBwcm9k dWN0cyB0by B2YXJpb3Vz IG1hcmtldH Mgd29ybGR3 aWRlLiBUaG UgY29tcGFu eSBlbnN1cm VzIHRoZSBo aWdoZXN0IH N0YW5kYXJk cyBvZiBxdW FsaXR5IGFu ZCBjb21wbG lhbmNlIGlu IGl0cyBtYW 51ZmFjdHVy aW5nIHByb2 Nlc3NlcyB0 byBtZWV0IH JlZ3VsYXRv cnkgcmVxdW lyZW1lbnRz Ljxicj40Li BNYXJrZXRp bmcgYW5kIF NhbGVzOiBB c3RlbGxhcy BQaGFybWEg bWFya2V0cy BpdHMgcHJv ZHVjdHMgdG hyb3VnaCBh IG5ldHdvcm sgb2Ygc2Fs ZXMgcmVwcm VzZW50YXRp dmVzIHRvIG hlYWx0aGNh cmUgcHJvZm Vzc2lvbmFs cyBhbmQgaG 9zcGl0YWxz LiBUaGUgY2 9tcGFueSB1 c2VzIHZhcm lvdXMgbWFy a2V0aW5nIH N0cmF0ZWdp ZXMgdG8gcm Fpc2UgYXdh cmVuZXNzIG FuZCBwcm9t b3RlIGl0cy Bwcm9kdWN0 cywgaW5jbH VkaW5nIHRy YWRpdGlvbm FsIGFkdmVy dGlzaW5nLC BtZWRpY2Fs IGNvbmZlcm VuY2VzLCBh bmQgZWR1Y2 F0aW9uYWwg cHJvZ3JhbX MuPGJyPjUu IEdsb2JhbC BHcm93dGgg YW5kIEV4cG Fuc2lvbjog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIG ZvY3VzZWQg YXBwcm9hY2 ggdG8gZXhw YW5kIGl0cy BnbG9iYWwg Zm9vdHByaW 50IGJ5IGVu dGVyaW5nIG 5ldyBtYXJr ZXRzLCBwYX J0aWN1bGFy bHkgaW4gZW 1lcmdpbmcg ZWNvbm9taW VzLCBhbmQg ZGl2ZXJzaW Z5aW5nIGl0 cyBwcm9kdW N0IHBvcnRm b2xpby4gVG hlIGNvbXBh bnkgYWxzby BzZWVrcyB0 byBlc3RhYm xpc2ggcGFy dG5lcnNoaX BzIHdpdGgg bG9jYWwgY2 9tcGFuaWVz IHRvIHN0cm VuZ3RoZW4g aXRzIHByZX NlbmNlIGlu IGRpZmZlcm VudCByZWdp b25zLjxicj 42LiBDb3Jw b3JhdGUgU2 9jaWFsIFJl c3BvbnNpYm lsaXR5IChD U1IpOiBBc3 RlbGxhcyBQ aGFybWEgaX MgY29tbWl0 dGVkIHRvIG dpdmluZyBi YWNrIHRvIH NvY2lldHkg YW5kIGZvc3 RlcmluZyBz dXN0YWluYW JsZSBncm93 dGggaW4gdG hlIGNvbW11 bml0aWVzIG l0IHNlcnZl cy4gVGhlIG NvbXBhbnkn cyBDU1IgcH JvZ3JhbXMg Zm9jdXMgb2 4gc3VwcG9y dGluZyBoZW FsdGhjYXJl IGluaXRpYX RpdmVzLCBw cm9tb3Rpbm cgZW52aXJv bm1lbnRhbC BzdXN0YWlu YWJpbGl0eS wgYW5kIGlu dmVzdGluZy BpbiBsb2Nh bCBjb21tdW 5pdGllcy48 YnI+SW4gc3 VtbWFyeSwg QXN0ZWxsYX MgUGhhcm1h J3MgYnVzaW 5lc3MgbW9k ZWwgcmV2b2 x2ZXMgYXJv dW5kIGludm VzdGluZyBp biBSJkQsIH N0cmF0ZWdp YyBwYXJ0bm Vyc2hpcHMg YW5kIGNvbG xhYm9yYXRp b25zLCBhIG dsb2JhbCBt YW51ZmFjdH VyaW5nIGFu ZCBzdXBwbH kgY2hhaW4s IG1hcmtldG luZyBhbmQg c2FsZXMsIG dsb2JhbCBn cm93dGggYW 5kIGV4cGFu c2lvbiwgYW 5kIGNvcnBv cmF0ZSBzb2 NpYWwgcmVz cG9uc2liaW xpdHkuIEJ5 IGZvbGxvd2 luZyB0aGlz IG1vZGVsLC B0aGUgY29t cGFueSBhaW 1zIHRvIG9m ZmVyIGlubm 92YXRpdmUg YW5kIGhpZ2 gtcXVhbGl0 eSBtZWRpY2 luZXMgdG8g aW1wcm92ZS BwYXRpZW50 IG91dGNvbW VzIGFuZCBj cmVhdGUgbG 9uZy10ZXJt IHZhbHVlIG ZvciBpdHMg c3Rha2Vob2 xkZXJzLg==
Interesting facts about the company
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
🚀 Don’t miss "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvS1 dxd2ZzYzh1 dVgyZmh6NX h2TUIud2Vi cCIgYWx0PS JBc3RlbGxh cyBQaGFybW EiIHRpdGxl PSJBc3RlbG xhcyBQaGFy bWEiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k4ggV2FudC B0byByZWFk IG1vcmUgYW JvdXQgQXN0 ZWxsYXMgUG hhcm1hPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TnSBKb2lu IHVzIGFuZC BncmFiIHlv dXIgY29weS BvZiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIAogIC AgICAgIAog ICAgICAgID xzcGFuIGNs YXNzPSdibH VycmVkLXRl eHQnPgogIC AgICAgICAg ICBNUzRnUV hOMFpXIHhz WVhNZ1VHaG ggY20xaElI ZGhjeSBCbW IzSnRaV1Fn IGFXNGdNak F3TlMgQjBh SEp2ZFdkby BJSFJvWlNC dFpYIEpuWl hJZ2IyWWcg ZEhkdklFcG hjRyBGdVpY TmxJSEJvIF lYSnRZV05s ZFggUnBZMk ZzSUdOdiBi WEJoYm1sbG N5IHdnV1dG dFlXNXYgZF dOb2FTQlFh RyBGeWJXRm paWFYwIGFX TmhiQ0JEYn kgNGdZVzVr SUVaMSBhbW x6WVhkaElG IEJvWVhKdF lXTmwgZFhS cFkyRnNJRS BOdkxqeGlj ajR5IExpQl VhR1VnWTIg OXRjR0Z1ZW VLQSBtWE1n WjJ4dlltIE ZzSUdobFlX UnggZFdGeW RHVnljeSBC cGN5QnNiMk 5oIGRHVmtJ R2x1SUYgUn ZhM2x2TENC SyBZWEJoYm l3Z1luIFYw SUdsMElHRn MgYzI4Z2FH RnpJRyBFZ2 MybG5ibWxt IGFXTmhibl FnY0ggSmxj MlZ1WTJVZy BhVzRnYjNS b1pYIElnWT I5MWJuUnkg YVdWeklITj FZMiBnZ1lY TWdkR2hsIE lGVnVhWFJs WkMgQlRkR0 YwWlhNcyBJ RVYxY205d1 pTIHdnWVc1 a0lFRnogYV dFdVBHSnlQ aiBNdUlFRn pkR1ZzIGJH RnpJSE53Wl cgTnBZV3hw ZW1WeiBJR2 x1SUdSbGRt IFZzYjNCcG JtY2cgWVc1 a0lHMWhibi BWbVlXTjBk WEpwIGJtY2 diV1ZrYVcg TnBibVZ6SU dsdSBJSE5s ZG1WeVlXIH dnZEdobGNt RncgWlhWMG FXTWdZWCBK bFlYTXNJR2 x1IFkyeDFa R2x1WnkgQj FjbTlzYjJk NSBMQ0J2Ym 1OdmJHIDlu ZVN3Z2FXMX QgZFc1dmJH OW5lUyB3Z1 lXNWtJR2x1 IFptVmpkR2 x2ZFggTWda R2x6WldGei BaWE11UEdK eVBqIFF1SU ZSb1pTQnUg WVcxbElFRn pkRyBWc2JH RnpJR2x6IE lHUmxjbWwy WlcgUWdabk p2YlNCMCBh R1VnUjNKbF pXIHNnZDI5 eVpITWcgWV hOMFpYSXNJ RyAxbFlXNX BibWNnIGMz UmhjaXdnWV cgNWtJR3h2 WjI5eiBMQ0 J0WldGdWFX IDVuSUhkdm NtUWcgYjNJ Z2JXVnpjMi BGblpTd2dj bVZ3IGNtVn paVzUwYVcg NW5JSFJvWl NCaiBiMjF3 WVc1NTRvIE NaY3lCamIy MXQgYVhSdF pXNTBJSCBS dklITm9hVz VwIGJtY2dZ U0JzYVcgZG 9kQ0J2YmlC dSBaWGNnYV dSbFlYIE1n WVc1a0lHSn kgYVc1bmFX NW5JSCBSb1 pXMGdkRzhn IGJHbG1aUz Q4WW4gSStO UzRnU1c0Zy BZV1JrYVhS cGIyIDRnZE c4Z2NHaGgg Y20xaFkyVj FkRyBsallX eHpMQ0JCIG MzUmxiR3ho Y3kgQmhiSE 52SUdoaCBj eUJoSUhOMG NtIDl1WnlC bWIyTjEgY3 lCdmJpQnla VyBkbGJtVn lZWFJwIGRt VWdiV1ZrYV cgTnBibVVn WVc1ayBJR2 x6SUdGamRH IGwyWld4NU lHbHUgZG1W emRHbHVaeS BCcGJpQnpk R1Z0IElHTm xiR3dnY20g VnpaV0Z5WT JnZyBZVzVr SUhSbFkyIG h1YjJ4dloz a3UgUEdKeV BqWXVJRSBG emRHVnNiR0 Z6IElHaGhj eUJpWlcgVn VJSEpsWTI5 biBibWw2Wl dRZ1ptIDl5 SUdsMGN5Qn ogZFhOMFlX bHVZVyBKcG JHbDBlU0Js IFptWnZjbl J6TEMgQnBi bU5zZFdScC BibWNnWW1W cGJtIGNnYm 1GdFpXUWcg YjI1bElHOW 1JSCBSb1pT QlhiM0pzIF pPS0FtWE1n VFcgOXpkQ0 JGZEdocCBZ MkZzSUVOdm JYIEJoYm1s bGN5QmkgZV NCMGFHVWdS WCBSb2FYTn dhR1Z5IFpT Qkpibk4wYV ggUjFkR1Vn Wm05eSBJSE 5sZG1WeVlX IHdnWTI5dW MyVmogZFhS cGRtVWdlVy BWaGNuTXVQ R0p5IFBqY3 VJRlJvWlMg QmpiMjF3WV c1NSBJR2x6 SUdOdmJXID FwZEhSbFpD QjAgYnlCbm FYWnBibSBj Z1ltRmpheU IwIGJ5QjBh R1VnWTIgOX RiWFZ1YVhS cCBaWE1nYV hRZ2MyIFZ5 ZG1WeklIUm 8gY205MVoy Z2dkbSBGeW FXOTFjeUJq IGIzSndiM0 poZEcgVWdj MjlqYVdGcy BJSEpsYzNC dmJuIE5wWW 1sc2FYUjUg SUhCeWIyZH lZVyAxekxD QnBibU5zIG RXUnBibWNn YzMgVndjRz l5ZEdsdSBa eUJvWldGc2 RHIGhqWVhK bElHRmogWT JWemN5Qmhi bSBRZ1pXUj FZMkYwIGFX OXVJR2x1YV ggUnBZWFJw ZG1WeiBMan hpY2o0NExp IEJKYmlBeU 1EQTQgTENC QmMzUmxiRy B4aGN5Qmla V05oIGJXVW dkR2hsSUcg WnBjbk4wSU hCbyBZWEp0 WVdObGRYIF JwWTJGc0lH TnYgYlhCaG Jua2dkRyA4 Z2NHRnlkRz VsIGNpQjNh WFJvSUggUm 9aU0JKYm5S bCBjbTVoZE dsdmJtIEZz SUZOd1lXTm wgSUZOMFlY UnBiMiA0Z0 tFbFRVeWtn IFRtRjBhVz l1WVcgd2dU R0ZpYjNKaC BkRzl5ZVN3 Z1kyIDl1Wk hWamRHbHUg WnlCeVpYTm xZWCBKamFD QnZiaUJoIG JuUnBMV05o Ym0gTmxjaU JrY25WbiBj eUJwYmlCdG FXIE55YjJk eVlYWnAgZE hrdVBHSnlQ aiBrdUlFRn pkR1ZzIGJH RnpJR2hoY3 kgQmhJSE4w Y205dSBaeU J3YVhCbGJH IGx1WlNCdl ppQnUgWlhj Z1lXNWtJRy BsdWJtOTJZ WFJwIGRtVW dkSEpsWVgg UnRaVzUwY3 l3ZyBkMmww YUNCdmRtIF Z5SURjd0lH TnMgYVc1cF kyRnNJSCBS eWFXRnNjeU JqIGRYSnla VzUwYkgga2 dkVzVrWlhK MyBZWGtnZD I5eWJHIFIz YVdSbExqeG kgY2o0eE1D NGdWRyBobE lHTnZiWEJo IGJua2dhR0 Z6SUggSmxZ MlZwZG1Way BJRzUxYldW eWIzIFZ6SU dGM1lYSmsg Y3lCaGJtUW djbSBWamIy ZHVhWFJwIG IyNXpJR1p2 Y2kgQnBkSE 1nY0hKdiBa SFZqZEhNc0 lIIEpsYzJW aGNtTm8gTE NCaGJtUWdZ biBWemFXNW xjM01nIGIz QmxjbUYwYV cgOXVjeXdn YVc1aiBiSF ZrYVc1bklH IEpsYVc1bk lHNWggYldW a0lHOXVaUy BCdlppQjBh R1VnIFZHOX dJRFV3SUUg TnZiWEJoYm 1sbCBjeUJt YjNJZ1JHIG wyWlhKemFY UjUgSUdKNU lFUnBkbSBW eWMybDBlVW x1IFl5ND0K ICAgICAgIC A8L3NwYW4+ CiAgICAgIC AgCiAgICAg ICAg
See Company Q&A
📊 Get full analytics about Astellas Pharma
Sign up for free
or
log in
⚡ Instantly access "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!
